Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery

Detalhes bibliográficos
Autor(a) principal: Taniguchi,Fábio P.
Data de Publicação: 2003
Outros Autores: Pêgo-Fernandes,Paulo M., Jatene,Fabio B., Kwasnicka,Karina L., Strumz,Célia M. C., Oliveira,Sérgio A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000300004
Resumo: OBJECTIVES: To evaluate the prognostic implications of myocardial creatine kinase and troponin I (cTn I) in blood samples from the coronary sinus of patients submitted to coronary artery bypass surgery both with and without ischemic preconditioning. METHODS: From October 1998 to May 1999, 35 patients with coronary artery disease who were submitted to coronary artery bypass surgery were studied. Samples containing creatine kinase and cTn I were obtained from the great cardiac vein during surgery at the onset of cardiopulmonary bypass, at the end of the first anastomosis, and at the end of cardiopulmonary bypass. In May 2002, 29 patients were evaluated in regards to the angina functional class, congestive heart failure, number of hospitalizations, myocardial infarction and death. There were 15 patients in the Preconditioned group and 14 in the Control group. Each group was subdivided into patients with and without cardiovascular symptoms. RESULTS: The Control and Preconditioned groups were not significantly different in relation to frequency of cardiovascular symptoms. There were progressive increases of the creatine kinase and cTn I levels at different Interval s of the study. The cTn I in the Preconditioned group was 1.21 ± 0.64 ng/mL and 3.19 ± 3.21 ng/mL in the Control group (p<0.05). The Control group with symptoms had the highest level for cTn I of 5.07 ± 3.69 ng/mL, significantly higher than all other groups (p<0.05). CONCLUSIONS: The Preconditioned group had the lowest level of cTn I. The cTn I may be a marker for late evolution in patients submitted to coronary artery bypass surgery.
id SBCCV-1_937e432d0d41ec1a619166724dd1cb42
oai_identifier_str oai:scielo:S0102-76382003000300004
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgeryMyocardial revascularizationMyocardial ischemic preconditioningMyocardial ischemia/physiologyTroponinOBJECTIVES: To evaluate the prognostic implications of myocardial creatine kinase and troponin I (cTn I) in blood samples from the coronary sinus of patients submitted to coronary artery bypass surgery both with and without ischemic preconditioning. METHODS: From October 1998 to May 1999, 35 patients with coronary artery disease who were submitted to coronary artery bypass surgery were studied. Samples containing creatine kinase and cTn I were obtained from the great cardiac vein during surgery at the onset of cardiopulmonary bypass, at the end of the first anastomosis, and at the end of cardiopulmonary bypass. In May 2002, 29 patients were evaluated in regards to the angina functional class, congestive heart failure, number of hospitalizations, myocardial infarction and death. There were 15 patients in the Preconditioned group and 14 in the Control group. Each group was subdivided into patients with and without cardiovascular symptoms. RESULTS: The Control and Preconditioned groups were not significantly different in relation to frequency of cardiovascular symptoms. There were progressive increases of the creatine kinase and cTn I levels at different Interval s of the study. The cTn I in the Preconditioned group was 1.21 ± 0.64 ng/mL and 3.19 ± 3.21 ng/mL in the Control group (p<0.05). The Control group with symptoms had the highest level for cTn I of 5.07 ± 3.69 ng/mL, significantly higher than all other groups (p<0.05). CONCLUSIONS: The Preconditioned group had the lowest level of cTn I. The cTn I may be a marker for late evolution in patients submitted to coronary artery bypass surgery.Sociedade Brasileira de Cirurgia Cardiovascular2003-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000300004Brazilian Journal of Cardiovascular Surgery v.18 n.3 2003reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.1590/S0102-76382003000300004info:eu-repo/semantics/openAccessTaniguchi,Fábio P.Pêgo-Fernandes,Paulo M.Jatene,Fabio B.Kwasnicka,Karina L.Strumz,Célia M. C.Oliveira,Sérgio A.eng2003-12-16T00:00:00Zoai:scielo:S0102-76382003000300004Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2003-12-16T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
title Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
spellingShingle Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
Taniguchi,Fábio P.
Myocardial revascularization
Myocardial ischemic preconditioning
Myocardial ischemia/physiology
Troponin
title_short Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
title_full Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
title_fullStr Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
title_full_unstemmed Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
title_sort Prognostic implications of myocardial creatine kinase and cardiac troponin in coronary artery bypass surgery
author Taniguchi,Fábio P.
author_facet Taniguchi,Fábio P.
Pêgo-Fernandes,Paulo M.
Jatene,Fabio B.
Kwasnicka,Karina L.
Strumz,Célia M. C.
Oliveira,Sérgio A.
author_role author
author2 Pêgo-Fernandes,Paulo M.
Jatene,Fabio B.
Kwasnicka,Karina L.
Strumz,Célia M. C.
Oliveira,Sérgio A.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Taniguchi,Fábio P.
Pêgo-Fernandes,Paulo M.
Jatene,Fabio B.
Kwasnicka,Karina L.
Strumz,Célia M. C.
Oliveira,Sérgio A.
dc.subject.por.fl_str_mv Myocardial revascularization
Myocardial ischemic preconditioning
Myocardial ischemia/physiology
Troponin
topic Myocardial revascularization
Myocardial ischemic preconditioning
Myocardial ischemia/physiology
Troponin
description OBJECTIVES: To evaluate the prognostic implications of myocardial creatine kinase and troponin I (cTn I) in blood samples from the coronary sinus of patients submitted to coronary artery bypass surgery both with and without ischemic preconditioning. METHODS: From October 1998 to May 1999, 35 patients with coronary artery disease who were submitted to coronary artery bypass surgery were studied. Samples containing creatine kinase and cTn I were obtained from the great cardiac vein during surgery at the onset of cardiopulmonary bypass, at the end of the first anastomosis, and at the end of cardiopulmonary bypass. In May 2002, 29 patients were evaluated in regards to the angina functional class, congestive heart failure, number of hospitalizations, myocardial infarction and death. There were 15 patients in the Preconditioned group and 14 in the Control group. Each group was subdivided into patients with and without cardiovascular symptoms. RESULTS: The Control and Preconditioned groups were not significantly different in relation to frequency of cardiovascular symptoms. There were progressive increases of the creatine kinase and cTn I levels at different Interval s of the study. The cTn I in the Preconditioned group was 1.21 ± 0.64 ng/mL and 3.19 ± 3.21 ng/mL in the Control group (p<0.05). The Control group with symptoms had the highest level for cTn I of 5.07 ± 3.69 ng/mL, significantly higher than all other groups (p<0.05). CONCLUSIONS: The Preconditioned group had the lowest level of cTn I. The cTn I may be a marker for late evolution in patients submitted to coronary artery bypass surgery.
publishDate 2003
dc.date.none.fl_str_mv 2003-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000300004
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382003000300004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-76382003000300004
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.18 n.3 2003
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126595037921280